Anzeige
Mehr »
Montag, 28.07.2025 - Börsentäglich über 12.000 News
Warum Analysten in diesem veganen Gamechanger viel mehr sehen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DPS4 | ISIN: SE0008613731 | Ticker-Symbol: 9II
Frankfurt
25.07.25 | 08:21
0,033 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOVICA INTERNATIONAL AB Chart 1 Jahr
5-Tage-Chart
BIOVICA INTERNATIONAL AB 5-Tage-Chart

Aktuelle News zur BIOVICA INTERNATIONAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
BIOVICA INTERNATIONAL Aktie jetzt für 0€ handeln
FrBiovica International: Biovica Launches DiviTum TKa for Use in Early Breast Cancer185UPPSALA, SE / ACCESS Newswire / July 25, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, today announces the launch of DiviTum...
► Artikel lesen
DoBiovica International: Biovica Awarded 3 MSEK Contract - 4th from Leading Tier-1 Pharma Company197UPPSALA, SE / ACCESS Newswire / July 24, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announced its fourth's work order...
► Artikel lesen
14.07.Announcement from Extra General Meeting in Biovica International AB440UPPSALA, SE / ACCESS Newswire / July 14, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Today on 14 July 2025 the extra general meeting of Biovica International AB (the "Company")...
► Artikel lesen
14.07.XFRA CAPITAL ADJUSTMENT INFORMATION - 14.07.2025194Das Instrument 8L8C US5303073051 LIBERTY BROADBAND C EQUITY wird cum Kapitalmassnahme gehandelt am 14.07.2025 und ex Kapitalmassnahme am 15.07.2025 The instrument 8L8C US5303073051 LIBERTY BROADBAND...
► Artikel lesen
27.06.Biovica International AB - Annual Report for the Financial Year 2024/2025 Published273UPPSALA, SE / ACCESS Newswire / June 27, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Annual Report for the finacial year 2024/2025 for Biovica International AB is published...
► Artikel lesen
26.06.Biovica International: Biovica Granted New European Patent246UPPSALA, SE / ACCESS Newswire / June 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica today announced that the European Patent Office (EPO) has granted a new patent for...
► Artikel lesen
18.06.Biovica International: Year-End Report 2024/2025276UPPSALA, SE / ACCESS Newswire / June 18, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Positive development in the USA continuesSEK tQ424/25Q423/24May-April 24/25May-April 23/24Net...
► Artikel lesen
11.06.Biovica International: Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company259UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement...
► Artikel lesen
11.06.Notice of Extra General Meeting in Biovica International AB283UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), are...
► Artikel lesen
11.06.Biovica International: Biovica Resolves on a Fully Guaranteed Rights Issue of Approximately SEK 80 million at SEK 0.63 Per Share254NOT TO BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA...
► Artikel lesen
10.06.Biovica International: Biovica Announces Financial Targets Following Key Partnerships and Commercial Progress291UPPSALA, SE / ACCESS Newswire / June 10, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces financial goals for...
► Artikel lesen
10.06.Biovica International: Biovica Secures Three New Work Orders in Pharma Services of 2,5 MSEK in Value215UPPSALA, SE / ACCESS Newswire / June 10, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, has signed three new work orders within...
► Artikel lesen
23.05.Biovica International: New DiviTum TKa Data to be Presented at ASCO in Three Cancer Types280UPPSALA, SE / ACCESS Newswire / May 23, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in cancer monitoring, today announces that three abstracts based on studies...
► Artikel lesen
19.05.Biovica International: Biovica Signs Major Service Agreement and First Study Work Order of 4 MSEK251UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces the signing of a Master...
► Artikel lesen
13.05.Biovica International: Biovica Collaborates with Tempus to Expand the Commercial Reach of DiviTum TKa417UPPSALA, SE / ACCESS Newswire / May 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, has entered a reference lab agreement...
► Artikel lesen
26.03.Biovica International: DiviTum TKa Data in Combination with Inflammation Proteins Presented at the AACR Meeting Enhance Precision to Predict Efficacy of Immunotherapy384UPPSALA, SE / ACCESS Newswire / March 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract...
► Artikel lesen
13.03.Biovica International AB receives observation status142Today, March 13, 2025, Biovica International AB (the "Company") disclosed its financial report for the period November 2024 - January 2025 with information on the Company's financial situation. The...
► Artikel lesen
13.03.Biovica International: Biovica Q3 Interim report Nov 2024 - Jan 2025320UPPSALA, SE / ACCESS Newswire / March 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentiallySEK tQ3 24/25Q3 23/24May-Jan...
► Artikel lesen
12.03.Biovica International: Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment342UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader in blood-based cancer monitoring, announces a partnership with...
► Artikel lesen
10.03.Biovica International: Biovica Signs New Work Order with US Biotech Company for TKa Testing Services272UPPSALA, SE / ACCESS Newswire / March 10, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has secured a new work order (WO) valued...
► Artikel lesen
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1